24 May 2013
Keywords: news, brief, aeterna, begin, phase, iii, trial
Article | 20 January 1997
- AEterna is to begin a Phase III trial of Neovastat, previouslycode-named AE-941, in patients with solid tumor cancers refractory to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com